A New Era for Dental Implants: Minimally Invasive Procedures gain Traction

The dental implant sector is witnessing a important shift, driven by innovations that prioritize patient comfort and procedural efficiency. Among the companies leading this conversion is Innobio Surg, whose ‘IBS Implant’ is rapidly gaining recognition for its unique approach to tooth replacement. Their innovative techniques are challenging customary methods and attracting attention both domestically and internationally.

Innobio Surg’s Innovative Edge: The ‘Uneven Incess-Minimum Invasive Implant Treatment’

Innobio Surg distinguishes itself through its pioneering ‘uneven incess-minimum invasive implant treatment.’ This method minimizes trauma to the patient by eliminating the need to cut the gums and expose the jawbone during implant placement. This approach contrasts sharply with conventional implant procedures, which often involve extensive surgery and bone grafting.

The company’s commitment to innovation was recognized last year when it received the Dong Pagoda medal in the Management Innovation Division at the Small and Medium Business Technology Management Innovation Competition, hosted by the Small and Medium Venture Business Department. This accolade underscores the potential of Innobio Surg’s technology to revolutionize the dental implant landscape.

Navigating a Competitive Landscape

The dental implant market is notoriously competitive, with numerous domestic and international players vying for market share. The implant penetration rate is high, reflecting a strong demand for tooth replacement solutions. However,this also means that new entrants face significant hurdles in gaining traction. Innobio Surg’s emergence as a “dark horse” in this arena highlights the appeal of its unique value proposition.

The Key Differentiator: Product Competitiveness

According to a representative from Innobio Surg, the key to their success lies in the product’s inherent competitiveness. The treatment paradigm is entirely different from the existing implants. Unlike traditional implants that require gum incisions and jawbone preparation,the IBS implant allows for immediate placement without exposing the jawbone. This minimum invasion approach marks a new era of implant surgery.

Understanding the ‘Uneven and Minimal Invasive Treatment’

Traditional implant procedures typically involve multiple components, including artificial roots, abutments, and artificial teeth. The process often requires cutting the gums, flattening the jawbone, and perhaps bone grafting, leading to significant patient discomfort and a higher risk of inflammation. In contrast, Innobio Surg’s implants feature an integrated design where the artificial root extends up to the gums. This eliminates the need for a separate abutment, streamlining the procedure, reducing patient pain, and minimizing the risk of gum inflammation.

Challenges and Opportunities for Dentists

While patients are enthusiastic about the minimally invasive nature of the IBS Implant,some dentists may face a learning curve in adopting the new procedure. The representative acknowledged this, stating that some dentists may be hesitant to abandon established methods and learn new techniques.Furthermore, compatibility issues may arise when managing existing patients who have undergone traditional implant procedures.

Despite these challenges, the potential benefits of the IBS Implant, including reduced patient discomfort and improved clinical outcomes, are likely to drive increasing adoption among dentists seeking to offer cutting-edge solutions.

The Future of Dental Implants

Innobio Surg’s success underscores the growing demand for minimally invasive dental procedures. As technology continues to advance, patients can expect even more innovative solutions that prioritize comfort, efficiency, and long-term oral health. The company’s expansion into the US market signals a broader trend towards the adoption of advanced dental technologies worldwide.

Challenging the Status Quo: A New Approach to Dental Implants

Innovio Surge CEO,Wang,is embarking on an aspiring journey to transform the dental implant landscape in the United States. His vision centers around a novel ‘unpaid-minimum invasive treatment’ approach, aiming to address the issues of cost and quality that plague the current market.

Wang acknowledges the challenges ahead, drawing parallels with the initial skepticism faced by Per-Ingvar Brånemark, frequently enough hailed as the father of dental implants. Brånemark’s pioneering titanium implant surgery, despite its eventual success, initially struggled for acceptance, even in his native Sweden.Wang hopes to mirror Brånemark’s eventual triumph, but this time on American soil.

Brenethak presented amazing results in 1982 after a long research with the University of Toronto, Canada. The 10-year survival rate (as of 1975) of the past surgery was 39%-maxillary 65%, but the 10-year survival rate of Brenemak surgery was 94%maxillary-97%. Since then, the artificial root made of titanium is planted at the same height as the jawbone, and the surgical method of connecting a separate landlord has been established.

Strategic Shift: From Product Push to Education and Network Building

Recognizing past missteps, Wang is adopting a revised strategy for the US market.Instead of solely focusing on product sales, the emphasis will be on educating American dentists about the ‘unpaid-minimum invasive treatment’. This involves showcasing the entire implant procedure, from start to finish, through practical demonstrations rather than theoretical lectures.

Las Vegas has been selected as the initial base of operations. The plan is to cultivate a network of dentists proficient in the innovio Surge implant procedure, who will then serve as advocates in key metropolitan areas such as Los Angeles, San Diego, San Jose, Houston, and Sacramento. A centralized call center will connect patients with qualified practitioners within the network.

Addressing the Cost vs.Quality Dilemma

wang is candid about the limitations of implementing this approach in Korea, citing intense price competition that compromises quality. While Korea boasts one of the highest implant penetration rates globally, it also suffers from some of the lowest costs, leading to substandard procedures and ultimately, patient dissatisfaction.

The typical lifespan of a dental implant is 10-15 years. However, Wang notes that implants performed at drastically reduced prices often fail within five years due to compromised techniques and materials. he advocates for mandatory implant warranty periods to protect patients from such outcomes.

According to the american Academy of Implant Dentistry (AAID), proper implant maintenance and regular check-ups are crucial for long-term success. Factors such as periodontal disease and occlusal adjustments play a significant role in implant longevity.

Patient Beware: Navigating the Implant Maze

Wang cautions patients against opting for the cheapest options, advising them to carefully evaluate the product, surgical procedure, and the dentist’s qualifications. He warns against deals that seem too good to be true, as they often involve compromises in quality and care.

Cheap Biji Tteok. If you do an implant, you need to carefully examine your product, surgery, and dentist career. it’s good to avoid cheap places. If artificial teeth are broken within 8 years, or artificial roots are missing within 10 years, it is not normal surgery.

He emphasizes the importance of addressing periodontal disease, a major cause of implant failure. Furthermore, he stresses the need for occlusal adjustments in the six months following surgery to ensure proper bite alignment and prevent undue stress on the implant.

About Innovio Surge CEO Wang

Wang is a graduate of Wonkwang University Dental College and graduate School. He served as CEO of Hyewon Dental Clinic from 1992 to 2003 and has been the CEO of Innovio Surge since 2008.

Challenging Conventional Implant Procedures

In the realm of dental prosthetics, a new approach is gaining traction, challenging traditional methods and offering patients a less invasive alternative. Wang Je-won, the driving force behind Innovio Surge, has developed the ‘IBS Implant’ system, a minimally invasive technique that is drawing comparisons to the groundbreaking work of Professor Per-Ingvar Brånemark, who pioneered titanium dental implants.

The Rise of Minimally Invasive Implantology

Just as transparent aligners like Invisalign have revolutionized orthodontics, offering a discreet alternative to traditional braces, the IBS Implant aims to transform implant dentistry. Wang’s approach focuses on reducing patient discomfort and accelerating recovery times by eliminating the need for extensive gum incisions.

“There have been twice in the history of dental therapy… Professor Fur Inbar Brenemak (titanium implant) and Harold Ketchling dentist (transparent treatment) are considered a representative figure who wrote a new history of dental treatment.”

This paradigm shift aligns with a growing trend in medicine towards minimally invasive procedures, driven by patient demand and technological advancements. According to the American Academy of Implant dentistry (AAID), the demand for dental implants is steadily increasing, with over 500,000 implants placed annually in the United States alone. As the population ages and awareness of implant options grows, the need for less invasive techniques becomes even more critical.

From Local Clinic to Global Innovation

Wang’s journey began in 1992, after graduating from Wonkwang University Dental College, when he opened the Hyewon Dental Clinic in a rural area of South Korea. Dissatisfied with the invasiveness of existing implant procedures, he embarked on a quest to develop a better solution.

“I started my studies on implant treatment with my own implant training course, which was run by a professor who studied in Sweden, a home home… This treatment process has been suffering for a while with the self -confidence that it was a surgery that could harm the health of the weak patients.”

Driven by a desire to minimize patient pain, Wang began researching incision-free implant techniques in 2003. His dedication led him to establish Innovio Surge in 2008 and introduce the IBS Implant system to the market.

Training the Next Generation of Implant Specialists

To promote his minimally invasive approach,Wang published a book titled AMII (Academy of Minimally Invasive Implantology) minimum invasive implant treatment and founded the AMII Training institute. To date, over 1700 dentists have been trained in his techniques, many of whom are now utilizing the Magicore implant system in their practices.

“I didn’t beleive that the implant procedure was possible promptly without the incision of the implant surgery, but I decided to create an independent implant manufacturing company, as Professor Brenet has been commercializing titanium implants in cooperation with Nobel BioCare (nobelpalma). Like a professor (laughs).”

The success of the IBS Implant system and the growing number of trained practitioners suggest a promising future for minimally invasive implantology. As more dentists adopt these techniques,patients can expect to benefit from reduced pain,faster recovery times,and improved overall outcomes.